GPT-5 Pro credited with cracking a three-year immunology problem

OpenAI reports that GPT-5 Pro helped immunologist Derya Unutmaz resolve a question about T cell behavior that had remained open for three years, work the company says could feed into cancer and autoimmune research. The account describes the model proposing a mechanistic insight that the researcher then pursued.

This is a vendor-published case study, not a peer-reviewed result, and the distinction matters. The claim is that a frontier model helped a working scientist past a specific obstacle. What is not yet established is whether the insight holds up under experimental validation and independent review, the standard that separates a useful hypothesis generator from a genuine engine of discovery.

Even read conservatively, the example fits a pattern of frontier models used as reasoning partners in the natural sciences rather than as text tools. The signal worth tracking is not a single solved problem but whether such assists become reproducible across laboratories and survive the move from a press post to a published paper.